Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
Neurology & Psychiatry
Filter     Order     Display # 
Date Item Title
14 Apr 2008 Genentech and Biogen Idec Announce Top-Line Results from a Phase II/III Clinical Trial of Rituxan in Primary-Progressive Multiple Sclerosis
11 Apr 2008 Status of the E2007 (perampanel) Development Program
11 Apr 2008 Santhera Presents Clinical Efficacy Data of SNT-MC17 in DMD at the American Academy of Neurology Annual Meeting
10 Apr 2008 Copaxone(R) Significantly Reduced Annual Relapse Rates And Stabilized Disease Progression In Relapsing Remitting Multiple Sclerosis Patients Failing Interferon Treatment
10 Apr 2008 Symbollon Pharmaceuticals Announces Results of IoGen Phase III Clinical Trial; No Statistically Significant Difference between Treatment Groups on the Primary Endpoint of Pain Reduction
10 Apr 2008 Copaxone® Significantly Reduced Annual Relapse Rates And Stabilized Disease Progression In Relapsing Remitting Multiple Sclerosis Patients Failing Interferon Treatment
09 Apr 2008 ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II StudyEvaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke
09 Apr 2008 Acorda Therapeutics Signs GGF2 Manufacturing Agreement with CMC ICOS
09 Apr 2008 Acorda Therapeutics Signs GGF2 Manufacturing Agreement with CMC ICOS
08 Apr 2008 Phase III MS Neuropathic Pain Trial Preliminary Results
08 Apr 2008 Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
08 Apr 2008 Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
08 Apr 2008 WEX Starts Phase III Trial of Tectin(TM) for Cancer Pain
07 Apr 2008 Danish biotech company's restorative Alzheimer's product has successfully been implanted in patients
07 Apr 2008 Biovitrum's unique neuropathic pain compound is very safe and shows positive effect
07 Apr 2008 MediciNova Reports Clinical Results From Two-Year Phase II Clinical Trial of MN-166 in Multiple Sclerosis
07 Apr 2008 NovaDel Announces Positive Data from Pilot Pharmacokinetic Study Comparing Tizanidine Oral Spray to Zanaflex(R) Tablets
07 Apr 2008 Transdel Pharmaceuticals Advances Lead Topical Pain Drug into Phase 3 Program
02 Apr 2008 Envivo Pharmaceuticals Announces Initiation of Clinical Safety and Biomarker Study of Alpha-7 Nicotinic Agonist, EVP-6124, in patients with Schizophrenia
02 Apr 2008 Eisai to Resume Clinical Study to Evaluate E2012
01 Apr 2008 Labopharm Appeals FDA's Decision on Once-Daily Tramadol to Next Supervisory Level After Additional Analysis Supports Efficacy
31 Mar 2008 Synosia Starts Phase II Efficacy Trial For Rufinamide
31 Mar 2008 Alnylam Presents Pre-clinical Data from Hypercholesterolemia, Liver Cancer, Ebola, and Progressive Multifocal Leukoencephalopathy (PML) Programs at RNAi Keystone Symposium
31 Mar 2008 Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease
31 Mar 2008 NeuroSearch initiates clinical Phase I study with NSD-788 for the treatment of anxiety and depression
31 Mar 2008 ACADIA Pharmaceuticals Initiates Second Phase III Trial with Pimavanserin in Patients with Parkinson's Disease Psychosis
31 Mar 2008 Gamma Secretase Modulators Show Promise in Alzheimer’s Disease Animal Model Efficacy Studies, According to Research Conducted by TorreyPines Therapeutics
28 Mar 2008 Neurologix Receives FDA Clearance to Initiate Phase 2 Trial in Parkinson's Disease Subjects
28 Mar 2008 Neurologix Receives FDA Clearance to Initiate Phase 2 Trial in Parkinson's Disease Subjects
28 Mar 2008 Evotec's EVT 101 Shown to Penetrate the Brain in Man and to Modulate Brain Activity during the Performance of Cognitive Tasks
27 Mar 2008 IntelliPharmaCeutics Announces Successful Completion of a Pilot Clinical Trial for its Abuse and Alcohol Resistant Sustained Release Oxycodone
25 Mar 2008 Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
20 Mar 2008 EPIX Pharmaceuticals Announces Discontinuation of PRX-00023 Clinical Development Program
20 Mar 2008 Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy for Chronic Lymphocytic Leukemia
19 Mar 2008 Zogenix Announces sumatriptan DosePro(TM) NDA Accepted for Filing by FDA
18 Mar 2008 Aegera initiates Phase 1 clinical trial of AEG33773 - A small molecule in development for diabetic neuropathic pain
18 Mar 2008 Peptimmune Completes Phase I Study with a Novel Peptide Copolymer for the Treatment of Multiple Sclerosis
17 Mar 2008 Targacept Initiates Clinical Development of TC-5214 as Augmentation Therapy for Major Depressive Disorder
15 Mar 2008 Medivation's Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimer's Disease Patients, Resulting in Reduced Caregiver Distress
14 Mar 2008 Eisai Submits Application for Aricept(R) Oral Jelly Formulation in Japan
13 Mar 2008 Teva Provides Update On Glatiramer Acetate 40mg For Amyotrophic Lateral Sclerosis (Als)
12 Mar 2008 M's Science and Eisai Sign Option Agreement for Sigma Agonist SA4503
11 Mar 2008 Opexa Therapeutics Announces Completion of Mid Study DescriptiveAnalysis on Phase IIb Trial of Tovaxin(R) for Treatment of Multiple Sclerosis
10 Mar 2008 Auriga Laboratories Announces FDA Approval of Liquadd(TM) (Dextroamphetamine Sulfate) Oral Solution for the Treatment of ADHD and Upcoming Product Launch
10 Mar 2008 Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen
10 Mar 2008 Alseres Pharmaceuticals Presents Inosine and Dopamine Transporter (DAT) Blocker Preclinical Data at the American Society for Experimental NeuroTherapeutics (ASENT) Conference
07 Mar 2008 Cortex Receives Approval from German Regulatory Authority to Proceed with Two Clinical Trials for AMPAKINE® CX717 for the Acute Treatment of Respiratory Depression Due to Opiate Analgesics
06 Mar 2008 Pixantrone to be Studied in Phase I/II Trial for Aggressive Multiple Sclerosis
06 Mar 2008 BTG Initiates Clinical Study of Novel Multiple Sclerosis Treatment
06 Mar 2008 Akela Pharma initiates its first abuse deterrent opioid Phase I clinical trial
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 301 - 350 of 1619

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics